T cell exhaustion

Search documents
SAB Biotherapeutics (SABS) Conference Transcript
2025-02-06 20:00
SAB Biotherapeutics (SABS) Conference February 06, 2025 02:00 PM ET Company Participants Samuel Reich - Chairman & CEO Conference Call Participants Yatin Suneja - Biotechnology Research Analyst Yatin Suneja Good afternoon, everyone. My name is Yatin Suneja, one of the biotech analysts here at Guggenheim. Welcome to our SMITCAP Biotech Conference. It is my pleasure to welcome our next presenting company, SAB Biotherapeutics from the company. We have a few executives here, but I'm gonna be having a chat with ...